Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ACTIMED THERAPEUTICS logo — Innovation in Cachexia

ACTIMED THERAPEUTICS

Innovation in Cachexia

Founded 2017 United Kingdom United Kingdom 14 employees Total: $14.55M Biotechnology, Pharmaceutical

General Information

Company Name ACTIMED THERAPEUTICS
Founded Year 2017
Location United Kingdom United Kingdom
Employees 14
Industries Biotechnology, Pharmaceutical
Business Model B2B, B2D
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with ACTIMED THERAPEUTICS. To contact ACTIMED THERAPEUTICS, visit actimedtherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ACTIMED THERAPEUTICS compare?

A PDF of ACTIMED THERAPEUTICS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ACTIMED THERAPEUTICS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ACTIMED THERAPEUTICS

ACTIMED THERAPEUTICS, founded in 2017, is a pioneering company based in the United Kingdom, focusing on innovative solutions in the fields of Biotechnology and Pharmaceutical. True to its slogan, "Innovation in Cachexia," the company is dedicated to advancing treatments for cachexia, a complex syndrome associated with severe chronic illnesses.

The company has drawn notable attention from the investment community, evidenced by its most recent injection of funds—a £1.00M Early VC investment—completed on 01 December 2023. This round was led by Mankind Pharma, signaling strong confidence in ACTIMED THERAPEUTICS' strategic trajectory and its potential to make significant impacts in unmet medical needs.

Overall, with its strategic focus and recent investor backing, ACTIMED THERAPEUTICS is positioning itself as a key player in the biotechnology and pharmaceutical sectors, illustrating substantial growth potential amid the burgeoning healthcare innovation landscape.

Business keywords: biopharmaceutical, clinical stage, muscle wasting disorders, cachexia treatment, anabolic agents, catabolic agents, cancer-related cachexia, chronic illness management, patient care transformation

Services & Products

R&D in Cachexia and Muscle Wasting conditions
Clinical Presentations
Pharmaceutical Licensing

Target Customers

Patients with cachexia Patients with muscle wasting conditions Healthcare providers Caregivers

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC £1.00M 1
Mankind Pharma
01 Dec 2023
Series A £4.75M 1
Mankind Pharma
01 Aug 2023
Seed £5.00M 1
Mankind Pharma
01 Jan 2023
Seed £2.50M -
01 Jun 2021
Seed £1.30M -
01 Oct 2018

ACTIMED THERAPEUTICS Alternatives & Competitors

View All Alternatives
ACTIMED THERAPEUTICS vs
AusperBio
AusperBio United States

Transforming Patient Lives For a Better Tomorrow

Series B
8 employees
Biopharma, Biotechnology
ACTIMED THERAPEUTICS vs
TheraCryf
TheraCryf United Kingdom

TheraCryf plc is a clinical stage therapeutics company developing a new generation of innovative the...

Post-IPO Equity
9 employees
Biotechnology, Pharmaceutical
ACTIMED THERAPEUTICS vs
PNP Therapeutics, Inc.
PNP Therapeutics, Inc.

Clinical-stage biopharmaceuticals developing cancer treatment platform with proprietary products

Seed
3 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About ACTIMED THERAPEUTICS

Innovation in Cachexia
ACTIMED THERAPEUTICS was founded in 2017.
ACTIMED THERAPEUTICS is headquartered in United Kingdom.
ACTIMED THERAPEUTICS operates in Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical, clinical stage, muscle wasting disorders and cachexia treatment. Its customers include Patients with cachexia, Patients with muscle wasting conditions and Healthcare providers.
ACTIMED THERAPEUTICS has a B2B and B2D business model. Its revenue comes from Licensing, Product Sales and Service Fee.
ACTIMED THERAPEUTICS has approximately 14 employees.
ACTIMED THERAPEUTICS has completed 5 funding rounds, raising a total of $14.55M.
ACTIMED THERAPEUTICS offers: R&D in Cachexia and Muscle Wasting conditions, Clinical Presentations, Pharmaceutical Licensing.
Top alternatives and competitors to ACTIMED THERAPEUTICS include AusperBio, TheraCryf, PNP Therapeutics, Inc., Stealth BioTherapeutics, Transgene. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ACTIMED THERAPEUTICS and AusperBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ACTIMED THERAPEUTICS, https://bouncewatch.com/company/actimed-therapeutics, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout